Phalanx Letrazole 2.5mg

Description

Phalanx Letrazole is the most potent aromatase inhibitor available — 2.5mg of Letrozole per tablet, a non-steroidal third-generation AI capable of reducing oestrogen levels by over 98% in clinical settings. This is not a compound for casual oestrogen management. Letrozole’s power places it in a different category from Anastrozole and Exemestane — deployed when other AIs aren’t cutting through elevated oestradiol, during heavy, high-aromatising cycles, or as a strategic tool for eliminating existing gynecomastia tissue (combined with targeted protocols). At 2.5mg, this is the clinical breast cancer treatment dose — extraordinarily potent for bodybuilding applications, where doses of 0.5–1mg every 2–3 days are more typical. Oestrogen crash is a real risk at full doses; precision and monitoring are essential. For breaking through existing gyno or managing severely elevated E2 on heavy cycles, Letrazole is the tool. Every tablet independently verified at 99%+ purity by Puralytix — handle with precision. For performance use, 0.5–1mg every 2–3 days is more typical than the full 2.5mg daily clinical dose — even aggressive aromaisers rarely require full clinical dosing. Bloodwork is non-negotiable when using Letrozole; its potency makes the margin between adequate oestrogen control and complete oestrogen crash narrow. The most powerful AI in the Phalanx range — deploy with precision.